Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $619.53M.
ENTERPRISE VALUE (EV)
$619.53M
Phathom Pharmaceuticals, Inc.
Market Cap
$540.42M
Enterprise Value (EV)
$619.53M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | $540.42M | $619.53M |
| Delcath Systems, Inc. (DCTH)vs › | $539.58M | $494.52M |
| ProKidney Corp. (PROK)vs › | $536.32M | $464.98M |
| Immix Biopharma, Inc. (IMMX)vs › | $533.68M | $309.19M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $549.33M | $530.16M |
| Nuvectis Pharma, Inc. (NVCT)vs › | $550.37M | $528.21M |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $552.54M | $480.54M |
| Monopar Therapeutics Inc. (MNPR)vs › | $524.44M | $471.79M |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $520.39M | $350.23M |
Market Cap
$540.42M
Total Debt
$209.09M
Cash
$129.97M
Enterprise Value
$619.53M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
